MLL Rearranged
KMT2A (MLL) rearrangements in acute leukemias. Targeted by emerging menin inhibitors (revumenib, ziftomenib).
No Drugs found for this biomarker.
KMT2A (MLL) rearrangements in acute leukemias. Targeted by emerging menin inhibitors (revumenib, ziftomenib).
No Drugs found for this biomarker.